Core Viewpoint - Cogent Communications Holdings, Inc. (NASDAQ:CCOI) is identified as a strong dividend stock with significant upside potential, with an average price target suggesting a 38% increase and a Street high indicating a potential 180% upside [1][2]. Financial Performance - For Q3 2025, Cogent reported service revenue of $241.9 million, reflecting a decrease of 1.7% from the previous quarter and a 5.9% decline year-over-year [3]. - On-net revenue for Q3 was $135.3 million, which is an increase of 2.2% from the preceding quarter but a decrease of 0.9% compared to Q3 2024 [3]. - Off-net revenue was reported at $95.1 million, down 14.5% year-over-year, while Wavelength revenue reached $10.2 million, marking a significant increase of 92.5% year-over-year [3]. - As of September 30, 2025, customer connections totaled 118,279, which is a decrease of 6.4% from the same quarter in 2024 and a slight decline of 0.4% from Q2 2025 [3]. Share Repurchase Initiative - Cogent Communications announced the resumption of its share repurchase initiative on November 17, allowing the company to buy back stock without a specified purchase amount [2]. Business Overview - Cogent Communications provides high-speed internet, private networks, and data center space globally, targeting small and medium-sized businesses, service providers, and other organizations [4].

Harmonic Investor Conference Call Summary Company Overview - **Company**: Harmonic (NasdaqGS:HLIT) - **Industry**: Video streaming technology Key Points M&A Announcement - Harmonic announced a binding offer from MediaKind to sell its video business segment for approximately **$145 million in cash** [4] - The transaction is expected to close in the **first half of 2026**, pending customary closing conditions and regulatory approvals [4] Strategic Implications - The sale is viewed as a **strategic and transformative transaction** that will enhance Harmonic's ability to expand its broadband business [4] - The transaction will allow Harmonic to leverage its expanding installed base and unlock additional growth opportunities [5] - The capital from the sale will be used to increase investment in Harmonic's rapidly growing **fiber business**, which is gaining traction among cable operators and telcos [5] Financial Impact - The pending sale is expected to provide a **healthy capital infusion**, part of which will support a **$200 million share repurchase program** [5] - The simplification of operations by no longer managing two distinct operational models is anticipated to improve operational effectiveness and agility [5] Future Outlook - Harmonic expressed confidence in MediaKind's ability to innovate and support customers post-sale, highlighting MediaKind's proven track record in the industry [6] - The company reaffirmed its guidance for **Q4 2025**, indicating stability in its financial outlook despite the pending sale [6] Upcoming Events - Harmonic will participate in a **Raymond James TMT and Consumer Conference** and a **Fireside Chat at the Barclays' 23rd Annual Global Technology Conference** [9] - These events will be webcast and available for viewing on Harmonic's Investor Relations website [9] Additional Notes - The call included a reminder that forward-looking statements are based on management's beliefs and assumptions, and actual results may differ due to various risks and uncertainties [2][3] - No questions were raised during the Q&A session, indicating a possible lack of immediate investor concerns or clarity on the transaction [8]

HINGHAM, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) -- HINGHAM INSTITUTION FOR SAVINGS (NASDAQ:HIFS) (“the Bank”), Hingham, Massachusetts, announced that its Board of Directors has authorized a share repurchase program (“the Program”) pursuant to which the Bank may repurchase up to $20 million of its outstanding common stock, having received all regulatory approvals as may be required. Under the Program, repurchases can be made from time to time using a variety of methods, which may include open market purchases ...

Financial Data and Key Metrics Changes - Consolidated revenues increased by 4.6% year over year, reaching a record of $1.065 billion, with organic growth of 3.4% [8][18] - Non-GAAP earnings per share (EPS) grew by 11% to $1.15, marking the eighth consecutive quarter of beating consensus earnings expectations [5][18] - Free cash flow for Q4 was strong at $150 million, with a total fiscal year repurchase of nearly $300 million, representing about two-thirds of free cash flow [5][19] Business Line Data and Key Metrics Changes - CooperVision reported revenue of $710 million, up 4.9% year over year, with organic growth of 3.2%, driven by improved availability of MyDay lenses [9][10] - CooperSurgical achieved quarterly revenue of $356 million, up 4% or 3.9% organically, with growth in fertility and surgical segments [14][15] Market Data and Key Metrics Changes - The Americas region grew by 5%, while EMEA grew by 3%, slightly below expectations due to market weakness in some countries [10][14] - Asia-Pacific was flat, primarily due to a 28% decline in China, attributed to weakness in low-margin e-commerce channels [10][12] Company Strategy and Development Direction - The company is focused on delivering consistent market share gains for CooperVision, with an emphasis on the MyDay Premium Daily Silicone Hydrogel Lens portfolio [4][6] - A formal strategic review has been initiated to explore opportunities for unlocking long-term shareholder value, including potential separation of business units [8][31][54] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about fiscal 2026, expecting strong revenue growth driven by MyDay sales and new private label contracts [39][60] - The company anticipates a conservative approach to guidance, particularly in the fertility segment, while remaining optimistic about long-term growth prospects [15][60] Other Important Information - The board authorized an increase in the share repurchase plan to $2 billion, reinforcing the commitment to returning capital to shareholders [6][19] - The company has successfully remediated material weaknesses related to IT controls from fiscal 2024 [24] Q&A Session Summary Question: Clariti product line performance - Clariti was down a couple of percent this quarter, approaching $400 million in annualized revenue, with ongoing efforts to reposition the product line [25][26] Question: Strategic review process - A strategic review is underway, with updates expected in the next earnings call, focusing on driving long-term shareholder value [30][31] Question: Market growth assumptions - The market is expected to grow at 4%-5% in fiscal 2026, with pricing power remaining stable [33][34] Question: Asia-Pacific market dynamics - The company faced challenges in Asia-Pacific, particularly in low-margin e-commerce channels, but expects less detriment in fiscal 2026 [37][38] Question: Free cash flow outlook - The increase in free cash flow is attributed to consistent performance and reduced capital expenditures, with expectations of over $2.2 billion in free cash flow from fiscal 2026 to 2028 [23][42] Question: Paragard product expectations - Guidance for Paragard includes conservatism due to potential competitive launches, with expectations for flat to low single-digit growth [55] Question: Pipeline and product launches - The company is excited about upcoming product launches, including MyDay and MiSight, which are expected to drive growth [58][59]

Core Points - CooperCompanies has appointed Colleen Jay as the new Chair of the Board, effective January 2, 2026, succeeding Robert Weiss, who will remain on the Board for reelection [1][2] - The company is undergoing a formal strategic review to identify opportunities for enhancing long-term shareholder value [1][4] Leadership Changes - Colleen Jay has been on the Board since 2016 and has a strong background in global operational leadership, having retired from Procter & Gamble in 2017 after 32 years [2] - Robert Weiss has been a significant figure in CooperCompanies' success for nearly five decades, serving in various leadership roles including CEO from 2007 to 2018 [3] Strategic Review - The strategic review aims to improve performance in core markets, expand market share, enhance operational efficiency, and generate strong returns through disciplined capital deployment [4] - The company plans to focus on share repurchases under a $2 billion share repurchase program during this review period [4] Company Overview - CooperCompanies operates in the medical device sector with two main business units: CooperVision, a leader in the contact lens industry, and CooperSurgical, focused on fertility and women's healthcare [5] - The company has a workforce of over 15,000 and sells products in more than 130 countries, positively impacting over 50 million lives annually [5]

SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today financial results for its fiscal fourth quarter and full year ended October 31, 2025. Fourth quarter 2025 revenue of $1,065.2 million, up 5%, or up 3% organically. Fiscal year 2025 revenue of $4.1 billion, up 5%, or up 4% organically.Fourth quarter 2025 GAAP diluted earnings per share (EPS) of $0.43, down 27%. Fiscal 2025 GAAP diluted EPS of $1.87, down 4%.Fourth quart ...

Core Viewpoint - Unum Group has announced a new share repurchase program, allowing the company to buy back up to $1 billion of its common stock starting January 1, 2026 [1] Summary by Relevant Sections - **Share Repurchase Program** - The board of directors has approved a new program for repurchasing shares [1] - The new program will authorize repurchases of up to $1 billion [1] - The current share repurchase program will remain effective until December 31, 2025, after which the new program will take effect [1]

Core Insights - Zumiez Inc. reported a significant increase in earnings per share for the third quarter, rising to $0.55 from $0.06 in the previous year, driven by strong sales growth and improved profitability [1][2][5] - Comparable sales for the third quarter increased by 7.6%, with North American comparable sales rising by 10.0% [1][2][5] - The company has seen a positive start to the fourth quarter, with comparable sales up 6.6% to date [1][5][6] Financial Performance - Net sales for the third quarter increased by 7.5% to $239.1 million, compared to $222.5 million in the same period last year [2][12] - Net income for the third quarter was $9.2 million, a significant improvement from $1.2 million in the prior year [2][12] - For the first nine months of fiscal 2025, total net sales increased by 4.5% to $637.7 million, with a net loss of $6.2 million, an improvement from a loss of $16.5 million in the same period last year [3][12] Cash Flow and Share Repurchase - As of November 1, 2025, the company had cash and current marketable securities totaling $104.5 million, up from $99.3 million a year earlier [4] - The company repurchased 0.3 million shares during the third quarter at an average cost of $18.61 per share, totaling $5.4 million [4][12] Fourth Quarter Outlook - The company projects fourth quarter net sales to be between $291 million and $296 million, representing a growth of 4.0% to 6.0% [7] - Expected consolidated operating margins for the fourth quarter are between 8.0% and 8.5%, with earnings per diluted share estimated at approximately $0.97 to $1.07 [7] Store Operations - Zumiez opened 6 new stores in fiscal 2025, including 5 in North America and 1 in Australia [7][10]

Core Insights - Raymond James Financial, Inc. (RJF) has initiated a new share repurchase program allowing for the buyback of up to $2 billion in shares, replacing the previous $1.5 billion plan announced in December 2024 [1][7] - The company has also increased its quarterly cash dividend by 8% to 54 cents per share, with the dividend payment scheduled for January 16, 2026 [2][7] - RJF's strong cash position of $11.4 billion and a manageable debt level of $700 million support the sustainability of its capital distribution strategy [3][4][7] Share Repurchase Program - The new share repurchase program has no expiration date and allows RJF to repurchase shares worth up to $2 billion [1][7] - As of December 2, 2025, approximately $105 million worth of shares were still available for repurchase under the previous plan [1] Dividend Announcement - The quarterly cash dividend of 54 cents per share reflects an 8% increase from the previous payout, continuing RJF's trend of regular dividend increases over the past decade [2][3] - The dividend will be paid to shareholders of record as of January 2, 2026 [2] Financial Position - RJF's annualized dividend yield stands at 1.26%, providing a steady income stream for investors, with a dividend payout ratio of 19% [3] - The company's cash and cash equivalents of $11.4 billion indicate a strong balance sheet, supporting its capital distribution strategy [3][4] Market Performance - Over the past six months, RJF's shares have increased by 10.7%, while the industry has seen a growth of 20.6% [5]

Core Insights - The Cooper Companies, Inc. is set to release its fourth-quarter earnings results on December 4, with expected earnings of $1.11 per share, an increase from $1.04 per share in the same period last year [1] - The consensus estimate for quarterly revenue is $1.06 billion, up from $1.02 billion a year earlier [1] Share Repurchase Program - The board of Cooper Companies approved a $1 billion increase in its share repurchase program on September 17 [2] Stock Performance - Cooper Companies shares rose 0.2% to close at $75.98 on Wednesday [3] Analyst Ratings - Wells Fargo downgraded the stock from Overweight to Equal-Weight with a price target of $72 [6] - Barclays initiated coverage with an Overweight rating and a price target of $85 [6] - JP Morgan maintained a Neutral rating and reduced the price target from $76 to $66 [6] - Baird maintained an Outperform rating and cut the price target from $97 to $85 [6] - Stifel maintained a Buy rating and lowered the price target from $90 to $85 [6]